I was saying that, from my research, I can see that mouse models have already been created to replicate each of these disorders, not that NNZ-2591 has necessarily been tested in mouse models of any of these disorders.
- Forums
- ASX - By Stock
- NEU
- Ann: Investor presentation, 15 May 2024
Ann: Investor presentation, 15 May 2024, page-33
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.15 |
Change
0.210(1.62%) |
Mkt cap ! $1.682B |
Open | High | Low | Value | Volume |
$13.23 | $13.35 | $13.02 | $2.374M | 179.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 440 | $13.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.15 | 655 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 319 | 13.120 |
4 | 611 | 13.110 |
6 | 1237 | 13.100 |
7 | 1418 | 13.090 |
4 | 512 | 13.080 |
Price($) | Vol. | No. |
---|---|---|
13.140 | 559 | 5 |
13.150 | 896 | 7 |
13.160 | 626 | 4 |
13.170 | 796 | 6 |
13.180 | 1385 | 5 |
Last trade - 12.39pm 14/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |